Company Filing History:
27 out of 39 
6 out of 250 
3 out of 3 Years Active: 2013-2025
Title: Innovations and Contributions of Inventor Sharon Shechter
Introduction
Sharon Shechter, an accomplished inventor based in Andover, MA, has made significant strides in the field of pharmaceutical innovations. With a total of 33 patents to her name, she has contributed to advancements in the treatment of disorders associated with CRM1 activity, among other areas. Her work not only reflects a commitment to improving healthcare but also showcases her innovative spirit in developing novel compounds.
Latest Patents
Among Sharon's latest patents are two notable inventions focusing on nuclear transport modulators. The first patent, titled "Nuclear transport modulators and uses thereof," introduces compounds of specific formulas and their pharmaceutically acceptable salts. This invention details pharmaceutical compositions that can be utilized in treating various disorders linked to CRM1 activity.
The second patent, "Hydrazide containing nuclear transport modulators and uses thereof," delves deeper into the realm of nuclear transport modulation. It specifically discusses CRM1 inhibitors and presents a compound represented by structural formula I. This patent emphasizes not only the synthesis of these compounds but also their application in treating and preventing physiological conditions related to CRM1 activity.
Career Highlights
Sharon Shechter's professional journey includes influential roles at Karyopharm Therapeutics Inc. and Biogen MA Inc. Her experiences at these prestigious companies have undoubtedly shaped her innovative approach and provided her with the platform to conduct significant research and development in her field.
Collaborations
Throughout her career, Sharon has collaborated with notable colleagues including Sharon Shacham and Dilara McCauley. These partnerships have been instrumental in advancing her research endeavors, enabling a productive exchange of ideas and fostering a collaborative environment for innovation.
Conclusion
In conclusion, Sharon Shechter stands out as a remarkable inventor whose contributions to pharmaceutical innovations continue to impact the field significantly. With her extensive patent portfolio and collaborative efforts, she exemplifies the spirit of innovation and dedication towards enhancing treatment options for various medical disorders. Her work reinforces the importance of innovation in driving advancements in healthcare.